Cargando…

Plant-based vaccines: unique advantages

Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability...

Descripción completa

Detalles Bibliográficos
Autores principales: Streatfield, Stephen J., Jilka, Joseph M., Hood, Elizabeth E., Turner, Debra D., Bailey, Michele R., Mayor, Jocelyne M., Woodard, Susan L., Beifuss, Katherine K., Horn, Michael E., Delaney, Donna E., Tizard, Ian R., Howard, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd. 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127671/
https://www.ncbi.nlm.nih.gov/pubmed/11257418
http://dx.doi.org/10.1016/S0264-410X(00)00512-0
_version_ 1783516411409203200
author Streatfield, Stephen J.
Jilka, Joseph M.
Hood, Elizabeth E.
Turner, Debra D.
Bailey, Michele R.
Mayor, Jocelyne M.
Woodard, Susan L.
Beifuss, Katherine K.
Horn, Michael E.
Delaney, Donna E.
Tizard, Ian R.
Howard, John A.
author_facet Streatfield, Stephen J.
Jilka, Joseph M.
Hood, Elizabeth E.
Turner, Debra D.
Bailey, Michele R.
Mayor, Jocelyne M.
Woodard, Susan L.
Beifuss, Katherine K.
Horn, Michael E.
Delaney, Donna E.
Tizard, Ian R.
Howard, John A.
author_sort Streatfield, Stephen J.
collection PubMed
description Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability, versatility and efficacy. Antigens expressed in corn are particularly advantageous since the seed can be produced in vast quantities and shipped over long distances at ambient temperature, potentially allowing global vaccination. We have expressed the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis virus at high levels in corn, and demonstrate that these antigens delivered in the seed elicit protective immune responses.
format Online
Article
Text
id pubmed-7127671
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Elsevier Science Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71276712020-04-08 Plant-based vaccines: unique advantages Streatfield, Stephen J. Jilka, Joseph M. Hood, Elizabeth E. Turner, Debra D. Bailey, Michele R. Mayor, Jocelyne M. Woodard, Susan L. Beifuss, Katherine K. Horn, Michael E. Delaney, Donna E. Tizard, Ian R. Howard, John A. Vaccine Article Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability, versatility and efficacy. Antigens expressed in corn are particularly advantageous since the seed can be produced in vast quantities and shipped over long distances at ambient temperature, potentially allowing global vaccination. We have expressed the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis virus at high levels in corn, and demonstrate that these antigens delivered in the seed elicit protective immune responses. Elsevier Science Ltd. 2001-03-21 2001-03-14 /pmc/articles/PMC7127671/ /pubmed/11257418 http://dx.doi.org/10.1016/S0264-410X(00)00512-0 Text en Copyright © 2001 Elsevier Science Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Streatfield, Stephen J.
Jilka, Joseph M.
Hood, Elizabeth E.
Turner, Debra D.
Bailey, Michele R.
Mayor, Jocelyne M.
Woodard, Susan L.
Beifuss, Katherine K.
Horn, Michael E.
Delaney, Donna E.
Tizard, Ian R.
Howard, John A.
Plant-based vaccines: unique advantages
title Plant-based vaccines: unique advantages
title_full Plant-based vaccines: unique advantages
title_fullStr Plant-based vaccines: unique advantages
title_full_unstemmed Plant-based vaccines: unique advantages
title_short Plant-based vaccines: unique advantages
title_sort plant-based vaccines: unique advantages
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127671/
https://www.ncbi.nlm.nih.gov/pubmed/11257418
http://dx.doi.org/10.1016/S0264-410X(00)00512-0
work_keys_str_mv AT streatfieldstephenj plantbasedvaccinesuniqueadvantages
AT jilkajosephm plantbasedvaccinesuniqueadvantages
AT hoodelizabethe plantbasedvaccinesuniqueadvantages
AT turnerdebrad plantbasedvaccinesuniqueadvantages
AT baileymicheler plantbasedvaccinesuniqueadvantages
AT mayorjocelynem plantbasedvaccinesuniqueadvantages
AT woodardsusanl plantbasedvaccinesuniqueadvantages
AT beifusskatherinek plantbasedvaccinesuniqueadvantages
AT hornmichaele plantbasedvaccinesuniqueadvantages
AT delaneydonnae plantbasedvaccinesuniqueadvantages
AT tizardianr plantbasedvaccinesuniqueadvantages
AT howardjohna plantbasedvaccinesuniqueadvantages